sc13d
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Advanced Biotherapy, Inc.
(Name of Issuer)
Common Stock, par value $.001 per share
(Title of Class of Securities)
Jeffrey R. Mistarz
Chief Financial Officer
Lime Energy Co.
280 Landmeier Road
Elk Grove Village, Illinois 60007
(847) 437-1666
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 18, 2008
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the
acquisition that is the subject of this Schedule 13D, and is filing this schedule
because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o
|
|
|
|
|
|
1 |
|
NAMES OF REPORTING PERSONS.
Lime Energy Co. |
|
|
|
|
|
|
2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
(a) o |
|
(b) o |
|
|
|
3 |
|
SEC USE ONLY |
|
|
|
|
|
|
|
4 |
|
SOURCE OF FUNDS (SEE INSTRUCTIONS) |
|
|
|
OO |
|
|
|
5 |
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) |
|
|
|
o |
|
|
|
6 |
|
CITIZENSHIP OR PLACE OF ORGANIZATION |
|
|
|
Delaware
|
|
|
|
|
|
7 |
|
SOLE VOTING POWER |
|
|
|
NUMBER OF |
|
-0- |
|
|
|
|
SHARES |
8 |
|
SHARED VOTING POWER |
BENEFICIALLY |
|
|
OWNED BY |
|
1,060,421,884 |
|
|
|
|
EACH |
9 |
|
SOLE DISPOSITIVE POWER |
REPORTING |
|
|
PERSON |
|
-0- |
|
|
|
|
WITH |
10 |
|
SHARED DISPOSITIVE POWER |
|
|
|
|
|
1,060,421,884 |
|
|
|
11 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
|
|
1,060,421,884 |
|
|
|
12 |
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) |
|
|
|
o
|
|
|
|
13 |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) |
|
|
|
90.8% |
|
|
|
14 |
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) |
|
|
|
CO |
TABLE OF CONTENTS
Item 1. Security and Issuer
The class of equity securities to which this Schedule 13D relates is the common stock, par
value $0.001 per share (the Common Stock), of Advanced Biotherapy, Inc., a corporation organized
under the laws of the State of Delaware (the Company). The principal executive offices of the
Company are located at 227 West Monroe, Suite 3900, Chicago, Illinois 60606.
Item 2. Identity and Background
This Schedule 13D is being filed by Lime Energy Co. (Lime), a corporation organized under
the laws of the State of Delaware. Limes principal business is providing energy efficiency
products and services. Limes principal business address and office is located at 1280 Landmeier
Road, Elk Grove Village, Illinois 60007.
(a) (c); (f) The name, business address, present principal occupation or employment, and the
name and principal business or any corporation or other organization in which such employment is
conducted of each of the executive officers and directors of Lime is set forth in Schedule I
attached hereto. Each person listed in Schedule I is a citizen of the United States.
(d) (e) During the last five years, neither Lime nor, to the knowledge of Lime, have any of
the persons listed on Schedule I, (i) been convicted in any criminal proceedings (excluding traffic
violations and similar misdemeanors) or (ii) been a party to any civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding was or is subject
to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation with respect to
such laws.
Item 3. Source and Amount of Funds or Other Consideration
On November 18, 2008, Lime entered into a Stock Purchase Agreement (the Purchase Agreement)
with certain stockholders of the Company to acquire a total of 1,060,421,884 shares of the Common
Stock of the Company in exchange for 2,252,341 shares of Limes common stock, par value $0.0001 per
share. The description of the Purchase Agreement contained in this Schedule 13D is qualified in
its entirety by reference to such agreement, which is incorporated by reference to Exhibit 1
hereto.
Item 4. Purpose of Transaction
The purpose of the Purchase Agreement was to obtain control of the Company. The acquisition
under the Purchase Agreement is subject to the approval of Limes stockholders under the NASDAQ
Marketplace Rules because Richard P. Kiphart is a director and significant shareholder of both Lime
and the Company, and Mr. Kiphart is selling 100% of his ADVB common stock to Lime under the
Purchase Agreement. Mr. Kipharts son-in-law, David W. Valentine, is also selling his ADVB stock
to Lime under the Purchase Agreement, and he serves as a director and stockholder of both Lime and
the Company. Lime expects to consummate the acquisition and become the owner of 1,060,421,884 of
the outstanding shares of Common Stock of the Company at least twenty days after the information
statement relating to the Purchase Agreement is sent to Lime stockholders. As a result, Lime will
hold 90.8% of the common
3
stock of the Company. Promptly following the closing of this acquisition, which is expected to
occur during the first quarter of 2009, Lime intends to effect a short-form merger with a wholly
owned subsidiary and the Company whereby the separate corporate existence of the Company will
terminate and each of the outstanding shares of the Common Stock of the Company not already owned
by Lime shall be converted into the Company shareholders choice of 0.002124 shares of Limes
common stock, which is the same exchange ratio under the Purchase Agreement, or $0.008625 for each
share of the ADVB common stock.. Lime intends to file a Form S-4 registration statement with
respect to the shares of Common Stock to be offered to the Company shareholders. Following the
short-form merger, the registration of the Companys common stock will terminate under the
Securities Exchange Act and the common stock will no longer be publicly traded on the OTC Bulletin
Board or elsewhere.
The terms of the Purchase Agreement require that Lime shall use its best efforts to cause the
President and CEO of the Company to be appointed to the board of directors of Lime.
Except as set forth above, neither Lime nor, to the knowledge of Lime, any of the persons
named on Schedule I, have any plans or proposals that would relate to or would result in any of the
matters referred to in paragraphs (a) through (j) of Item 4 of Schedule 13D.
Item 5. Interest in Securities of the Issuer
(a) and (b) As of November 18, 2008, Lime acquired the right to beneficially own an aggregate
of 1,060,421,884 shares of the Common Stock of the Company, which represented ownership of 90.8% of
the issued and outstanding stock of the Company. Mr. Kiphart is a director and Chairman of Lime
and its largest shareholder, and he is also a director and Chairman of the Company and its largest
shareholder. Mr. Valentine is also a director and stockholder of both companies. Because of this
overlapping interest, Lime may be deemed to share the power to vote and the power to dispose of
ADVB shares held by Messrs. Kiphart and Valentine. In addition, it is possible that the
acquisition of the ADVB shares under the Purchase Agreement will be completed within 60 days,
giving Lime the sole power to vote or direct the vote and the sole power to dispose of or direct
the disposition of these securities.
(c) Except as described in Item 4 hereof, no transactions in the Companys Common Stock were
effected by Lime, or to the knowledge of Lime, any of the persons listed on Schedule I hereto,
during the past 60 days.
(d) and (e) Not Applicable
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the
Issuer
Mr. Kiphart is a director and Chairman of Lime and its largest shareholder, and he is also a
director and Chairman of the Company and its largest shareholder. Mr. Valentine is also a director
and stockholder of both Lime and the Company. Mr. Valentine is a party to the Purchase Agreement.
Lime has agreed to pay the legal fees of Mr. Kiphart in his capacity as the representative of the
sellers under the Purchase Agreement.
Except as set forth in this Schedule 13D, to the knowledge of Lime, there are no other
contracts, arrangements, understandings or relationships (legal or otherwise) among the persons
named in Item 2 or listed on Schedule I hereto, and between such persons and any person with
respect to any securities of the
4
Company, including but not limited to, transfer or voting of any of the securities of the Company,
finders fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits,
division of profits or losses, or the giving or withholding of proxies, or a pledge or contingency
the occurrence of which would give another person voting power over the securities of the Company.
Item 7. Material to be Filed as Exhibits
Exhibit 1 Stock Purchase Agreement dated as of November 18, 2008 by and among Lime Energy
Co. and certain stockholders of Advanced Biotherapy, Inc (incorporated by reference to Exhibit 10.4
of the Current Report on Form 8-K of Lime Energy Co. filed on November 18, 2008 with the Securities
and Exchange Commission).
5
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the
information set forth in this statement is true, complete and correct.
Dated: November 24, 2008
LIME ENERGY CO.
|
|
|
|
|
By:
|
|
/s/ Jeffrey R. Mistarz
Name: Jeffrey R. Mistarz
|
|
|
|
|
Title: Chief Executive Officer |
|
|
6